Psilocybin-assisted Treatment for Cannabis Use Disorder (NCT06660381)
Pilot Study of Psilocybin-assisted Treatment for Cannabis Use Disorder
🩺 Plain-English Summary (8th-Grade Level)
This pilot study will evaluate the therapeutic potential of psilocybin in people with Cannabis Use Disorder (CUD). This study will examine the impact of psilocybin treatment on cannabis use and related variables in 12 people with CUD. This is an open-label proof-of-concept trial in which participants will complete a 12-week course of study treatment including two psilocybin sessions with psychological support, and follow-up assessments 3 and 6 months after the first psilocybin session.
Who can join: Review the eligibility criteria below.
Location: Johns Hopkins Center for Psychedelic and Consciousness Research — Baltimore, Maryland
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Johns Hopkins Center for Psychedelic and Consciousness Research — Baltimore, Maryland
📞 Contact the Study Coordinator
Phone: (410) 550-1972
Email: igeithn1@jhmi.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Cannabis Use Disorder
- Applying Neuromodulation to Boost the Efficacy of Motivational Interviewing — Albuquerque, New Mexico
- Emotional Brain Training for Addiction Medicine Treatment - A Pilot Study — San Bernardino, California
- Pregnenolone for Cannabis Use Disorder and Depression — Dallas, Texas
- SV2A Density Cannabis Use Disorder — New Haven, Connecticut
- Cannabidiol and Cannabis Concentrate Users — Aurora, Colorado
- RS-tDCS for Cannabis Use Disorder: The C.A.R.E.S. Initiative — New York, New York
Explore by condition: All Cannabis Use Disorder clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.